Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
When prescribing drugs for use outside their licence most
specialists in palliative medicine do not routinely obtain written or
formal consent from patients, document the reason for unlicensed use in the patient's notes, or inform other professionals of
unlicensed use, as has been recommended. When they do obtain consent,
it is likely to be for the use of less established drugs and to be verbal rather than written. In their questionnaire survey to all 182 palliative care services in the United Kingdom, Pavis and colleagues (p 484) also found that palliative care specialists do not
welcome strict adherence to these recommendations because of the number
of drugs involved and the burden to patients and carers. This view is
shared by the Royal College of Child Health, as the use of drugs
outside their licence is also common in
paediatrics.